Ioannis Koulas
Ioannis Koulas has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Alex C. Spyropoulos
Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY 11030, USA
3 shared publications Anne Myrka
IPRO, Albany, NY, USA
1 shared publication- Antonis Billis
Aristotle University of Thessaloniki
1 shared publication Dimitris Kola
1 shared publication- Dimitris Spachos
Aristotle University of Thessaloniki
1 shared publication - Eleni Dafli
Lab of Medical Physics and Digital Innovation, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece
1 shared publication
Latest Publications
- Open Access
Democratizing Virtual Patient Case Creation: A Proof-of-concept Technical Framework for Clinicians
Objective: Virtual patient cases are a scalable and engaging tool for training medical professionals. Strategies and frameworks for their implementation in teaching and training settings are few, technically complicated and/or expensive. We developed and evaluated open source and free virtual patient cases to test knowledge acquisition during an echocardiography training program for internal medicine trainees in Haiti. The objective of this paper is to describe the technical aspects of the GMENEcho virtual patient cases implementation and motivate similar work by resource-constrained teams. Methods: We used an open source engine for text-based games (Twine) since it provides the necessary interaction mechanics and is usable out-of-the-box. The case code was written in SugarCube 2.30.0 notation and the tweego-generated .html file was hosted on Github Pages for continuous integration and deployment, making iterations by the clinical team seamless. Data from completed tests were reported back via email through a third party integration. Results: The technical work was completed in two weeks by a team member with a clinical background and minimal computer programming experience. The virtual patient cases were deployed for a pretest (November 2023) and a second time unaltered for a posttest (June 2024) after the interim hands-on and theoretical training had been completed. Qualitative feedback was positive or neutral. The overall score in the posttest was significantly higher with a large effect size (mean absolute improvement 15.26%, p < 0.001; Cohen’s d: 1.398), similarly to the diagnostic score (mean absolute difference 16.09%, p < 0.001; Cohen’s d: 1.402). Management performance missed statistical significance by a small margin. The System Usability Scale (SUS) score was 74.6 (“Excellent”).There was reduced inter-trainee variability across metrics in the posttest, including the SUS score. Discussion: This proof-of-concept methodology can be applied to create clinical patient cases for use within a class or a clinical training setting, through a friendly graphical user interface. A more complex software stack can allow for remote or larger scale implementations with additional features. Conclusion: The rapid development time and positive qualitative and quantitative feedback highlight the potential of this approach for clinical education in resource-constrained settings. It can serve as a template for more streamlined adaptations of case-based learning in diverse healthcare settings.
Open AccessDemocratizing Virtual Patient Case Creation: A Proof-of-concept Technical Framework for Clinicians
Objective: Virtual patient cases are a scalable and engaging tool for training medical professionals. Strategies and frameworks for their implementation in teaching and training settings are few, technically complicated and/or expensive. We developed and evaluated open source and free virtual patient cases to test knowledge acquisition during an echocardiography training program for internal medicine trainees in Haiti. The objective of this paper is to describe the technical aspects of the GMENEcho virtual patient cases implementation and motivate similar work by resource-constrained teams. Methods: We used an open source engine for text-based games (Twine) since it provides the necessary interaction mechanics and is usable out-of-the-box. The case code was written in SugarCube 2.30.0 notation and the tweego-generated .html file was hosted on Github Pages for continuous integration and deployment, making iterations by the clinical team seamless. Data from completed tests were reported back via email through a third party integration. Results: The technical work was completed in two weeks by a team member with a clinical background and minimal computer programming experience. The virtual patient cases were deployed for a pretest (November 2023) and a second time unaltered for a posttest (June 2024) after the interim hands-on and theoretical training had been completed. Qualitative feedback was positive or neutral. The overall score in the posttest was significantly higher with a large effect size (mean absolute improvement 15.26%, p < 0.001; Cohen’s d: 1.398), similarly to the diagnostic score (mean absolute difference 16.09%, p < 0.001; Cohen’s d: 1.402). Management performance missed statistical significance by a small margin. The System Usability Scale (SUS) score was 74.6 (“Excellent”).There was reduced inter-trainee variability across metrics in the posttest, including the SUS score. Discussion: This proof-of-concept methodology can be applied to create clinical patient cases for use within a class or a clinical training setting, through a friendly graphical user interface. A more complex software stack can allow for remote or larger scale implementations with additional features. Conclusion: The rapid development time and positive qualitative and quantitative feedback highlight the potential of this approach for clinical education in resource-constrained settings. It can serve as a template for more streamlined adaptations of case-based learning in diverse healthcare settings.
- 8 November 2023
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 181, 105286
Longitudinal dynamic clinical phenotypes of in-hospital COVID-19 patients across three dominant virus variants in New York
- 8 November 2023
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 181, 105286
Longitudinal dynamic clinical phenotypes of in-hospital COVID-19 patients across three dominant virus variants in New York
- Open Access
- 1 January 2023
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 29
Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis
The Management of Anticoagulation in the Periprocedural Period (MAPPP) app is a free tool providing up-to-date guidelines on the periprocedural management of patients on long-term anticoagulants. After validating its effectiveness in the post-procedural period, we aimed to study its overall cost-effectiveness. SF-12 surveys were sent to eligible patients, converted into SF-6D forms, and subsequently into quality-adjusted life years (QALYs) to calculate the incremental cost-effectiveness ratio (ICER). The number of 30-day readmissions was used to calculate hospitalization costs, utilizing publicly available data. From 1/1/2018 to 1/31/2019, 642 patients were screened for enrollment, with an overall response rate of 94% (164/175) among the consented and 49% (164/336) among all eligible patients. The average QALY score was 0.7134 (95% CI [0.6836, 0.7431]) for the patients whose treatment plan followed the MAPPP app recommendations (acceptance group) and 0.7104 (95% CI [0.6760, 0.7448]) for those who did not (rejection group), without statistically significant differences. The difference in ICER scores was −$429 866.67, with the negative sign demonstrating that acceptance was the dominant strategy. By utilizing QALYs and ICER scores we have shown that the acceptance of MAPPP app recommendations is the dominant strategy for the periprocedural management of patients on long-term anticoagulation.
- 1 January 2023
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 29
Open AccessImplementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis
The Management of Anticoagulation in the Periprocedural Period (MAPPP) app is a free tool providing up-to-date guidelines on the periprocedural management of patients on long-term anticoagulants. After validating its effectiveness in the post-procedural period, we aimed to study its overall cost-effectiveness. SF-12 surveys were sent to eligible patients, converted into SF-6D forms, and subsequently into quality-adjusted life years (QALYs) to calculate the incremental cost-effectiveness ratio (ICER). The number of 30-day readmissions was used to calculate hospitalization costs, utilizing publicly available data. From 1/1/2018 to 1/31/2019, 642 patients were screened for enrollment, with an overall response rate of 94% (164/175) among the consented and 49% (164/336) among all eligible patients. The average QALY score was 0.7134 (95% CI [0.6836, 0.7431]) for the patients whose treatment plan followed the MAPPP app recommendations (acceptance group) and 0.7104 (95% CI [0.6760, 0.7448]) for those who did not (rejection group), without statistically significant differences. The difference in ICER scores was −$429 866.67, with the negative sign demonstrating that acceptance was the dominant strategy. By utilizing QALYs and ICER scores we have shown that the acceptance of MAPPP app recommendations is the dominant strategy for the periprocedural management of patients on long-term anticoagulation.
- 21 February 2022
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 122 (08) , 1279-1287
State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism
Venous thromboembolism (VTE) and arterial thromboembolism (ATE) are linked by the common mechanism of thrombin generation. Historically these entities have been treated as separate pathophysiologic processes requiring different treatments: VTE, as the formation of fibrin-/coagulation-factor-derived thrombus in low-flow vasculature, requiring anticoagulants; versus ATE, as largely platelet-derived thrombus in high-flow vasculature, requiring antiplatelet agents. Observational studies have elucidated shared risk factors and comorbidities predisposing individuals with VTE to ATE, and vice versa, and have bolstered the strategy of dual-pathway inhibition (DPI)—the combination of low-dose anticoagulants with antiplatelet agents—to reduce thrombotic outcomes on both sides of the vasculature. Randomized clinical trials have evaluated the efficacy and safety of such regimens—mostly rivaroxaban and aspirin—in high-risk groups of patients, including those with recent acute or chronic coronary syndrome, as well as those with peripheral artery disease with or without revascularization. Studies of extended VTE prophylaxis in acutely ill medical patients have also contributed to the evidence evaluating DPI. The totality of available data supports the concept that DPI can reduce major and fatal thromboembolic outcomes, including stroke, myocardial infarction, VTE, and cardiovascular death in key patient cohorts, with acceptable risk of bleeding. Further data are needed to refine which patients derive the best net clinical benefit from such an approach. At the same time, other novel agents such as contact pathway inhibitors that reduce thrombin generation without affecting hemostasis—and thus maximize safety—should be assessed in appropriate populations.
- 21 February 2022
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 122 (08) , 1279-1287
State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism
Venous thromboembolism (VTE) and arterial thromboembolism (ATE) are linked by the common mechanism of thrombin generation. Historically these entities have been treated as separate pathophysiologic processes requiring different treatments: VTE, as the formation of fibrin-/coagulation-factor-derived thrombus in low-flow vasculature, requiring anticoagulants; versus ATE, as largely platelet-derived thrombus in high-flow vasculature, requiring antiplatelet agents. Observational studies have elucidated shared risk factors and comorbidities predisposing individuals with VTE to ATE, and vice versa, and have bolstered the strategy of dual-pathway inhibition (DPI)—the combination of low-dose anticoagulants with antiplatelet agents—to reduce thrombotic outcomes on both sides of the vasculature. Randomized clinical trials have evaluated the efficacy and safety of such regimens—mostly rivaroxaban and aspirin—in high-risk groups of patients, including those with recent acute or chronic coronary syndrome, as well as those with peripheral artery disease with or without revascularization. Studies of extended VTE prophylaxis in acutely ill medical patients have also contributed to the evidence evaluating DPI. The totality of available data supports the concept that DPI can reduce major and fatal thromboembolic outcomes, including stroke, myocardial infarction, VTE, and cardiovascular death in key patient cohorts, with acceptable risk of bleeding. Further data are needed to refine which patients derive the best net clinical benefit from such an approach. At the same time, other novel agents such as contact pathway inhibitors that reduce thrombin generation without affecting hemostasis—and thus maximize safety—should be assessed in appropriate populations.
- Open Access
- 14 January 2021
- Published by SAGE Publications in Health Informatics Journal
- Vol. 27 (1)
Design and evaluation of mobile scenario based learning in the self-management of chronic pain
Chronic pain is a lifelong issue, being one of the main causes of disability, affecting a great number of people worldwide, many of which often avoid seeking medical advice from pain experts and/or demonstrate poor adherence to their therapeutic plan. One of the most important steps in achieving a manageable course of disease, is the ability of self-management. We aimed at applying a method of systematic patient education and self-management through the use of Virtual Patients (VPs), a well-established method for educating medical doctors and students but never before targeting patients. Two VPs scenarios were designed, tested and evaluated by patients with rheumatic disorders, achieving a SUS score of 88/100 “Best Imaginable”, alongside with positive reviews from the participants. The positive feedback from the patients supports the potential of VP educational paradigm to educate these patients and equip them with disease coping skills and strategies.
- 14 January 2021
- Published by SAGE Publications in Health Informatics Journal
- Vol. 27 (1)
Open AccessDesign and evaluation of mobile scenario based learning in the self-management of chronic pain
Chronic pain is a lifelong issue, being one of the main causes of disability, affecting a great number of people worldwide, many of which often avoid seeking medical advice from pain experts and/or demonstrate poor adherence to their therapeutic plan. One of the most important steps in achieving a manageable course of disease, is the ability of self-management. We aimed at applying a method of systematic patient education and self-management through the use of Virtual Patients (VPs), a well-established method for educating medical doctors and students but never before targeting patients. Two VPs scenarios were designed, tested and evaluated by patients with rheumatic disorders, achieving a SUS score of 88/100 “Best Imaginable”, alongside with positive reviews from the participants. The positive feedback from the patients supports the potential of VP educational paradigm to educate these patients and equip them with disease coping skills and strategies.